Type 2 Diabetes Trial, Not Yet Recruiting NCT06340828 Sponsor: The Second Hospital of Nanjing Medical University Condition: Type 2 Diabetes
Back to Type 2 Diabetes

Type 2 Diabetes Trial, Not Yet Recruiting

NCT06340828
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who have been diagnosed with type 2 diabetes and a diabetes-related condition that affects how the digestive system moves food through the body.
  • People whose blood sugar control measure (a test called HbA1c) is below 11.0%.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who depend on insulin to manage their diabetes.
  • People who have an active infection, are currently taking antibiotics, or have inflammatory bowel disease, irritable bowel syndrome, or another serious digestive condition.
  • People who have severe complications from their diabetes.
  • People who have a thyroid condition, cancer, severe difficulties with memory or thinking, or a serious mental health condition.
  • People with a history of alcohol or substance misuse.
  • People who are pregnant or currently breastfeeding.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 18 August 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +8615664579913

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
The Second Hospital of Nanjing Medical University
Registry
ClinicalTrials.gov
Start date
20 April 2024
Est. completion
20 July 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Gastrointestinal Symptom Rating Scale; Gut Microbiome Sequencing

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 18 August 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov